Literature DB >> 11080719

Tear and conjunctival changes during the allergen-induced early- and late-phase responses.

A S Bacon1, P Ahluwalia, A M Irani, L B Schwartz, S T Holgate, M K Church, J I McGill.   

Abstract

BACKGROUND: Allergic eye disease is common, but little is known about the underlying disease mechanisms. Conjunctival allergen challenge causes symptoms similar to those of seasonal allergic conjunctivitis and is a useful model to study.
OBJECTIVE: We have used allergen challenge to investigate the course of the ocular response, tear inflammatory mediators, tissue adhesion protein expression, and cellular infiltration.
METHODS: Eighteen atopic patients and 4 nonatopic control subjects were challenged with extracted mixed grass or Dermatophagoides pteronyssinus in one eye and control vehicle in the other. The clinical response was recorded, and tears were collected over a 6-hour period. Conjunctival biopsy specimens were taken from the challenged eye at 6 or 24 hours.
RESULTS: An early-phase response (maximal at 20 minutes) showed a significant increase in tear histamine and tryptase levels, reducing to control levels again by 40 minutes. At 6 hours, a late-phase response occurred with increased symptoms, a second peak of tear histamine and eosinophil cationic protein but not tryptase, upregulation of the adhesion molecules E-selectin and intercellular adhesion molecule, and a cellular infiltrate of mast cells, neutrophils, eosinophils, macrophages, and basophils, with T cells increased only in bulbar biopsy specimens.
CONCLUSIONS: The early peaks of tear histamine plus tryptase indicate that the mast cell is responsible for the early-phase response, but basophils may be involved in the late-phase response. Both tear and biopsy findings underline the significance of the late-phase response as the transition between a type I response and clinical disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080719     DOI: 10.1067/mai.2000.110930

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  20 in total

Review 1.  Conjunctival allergen challenge: models in the investigation of ocular allergy.

Authors:  Mark B Abelson; Oliver Loeffler
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

2.  Allergic conjunctivitis and nasal allergy.

Authors:  Zdenek Pelikan
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

Review 3.  Allergic conjunctivitis and the impact of allergic rhinitis.

Authors:  Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

Review 4.  Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut.

Authors:  Hugh R P Miller; Alan D Pemberton
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

Review 5.  [Ocular allergies].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

Review 6.  A review of the use of olopatadine in allergic conjunctivitis.

Authors:  James I McGill
Journal:  Int Ophthalmol       Date:  2004-05       Impact factor: 2.031

Review 7.  Causes and management of red eye in pediatric ophthalmology.

Authors:  Divya Seth; Farah I Khan
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

8.  Cellular changes in tears associated with keratoconjunctival responses induced by nasal allergy.

Authors:  Z Pelikan
Journal:  Eye (Lond)       Date:  2014-01-17       Impact factor: 3.775

Review 9.  Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.

Authors:  Leonard Bielory; C H Katelaris; Susan Lightman; Robert M Naclerio
Journal:  MedGenMed       Date:  2007-08-15

Review 10.  Allergy and the eye.

Authors:  A Leonardi; L Motterle; M Bortolotti
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.